nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—CACNA2D2—neck—esophageal cancer	0.0114	0.174	CbGeAlD
Isradipine—Transient ischaemic attack—Capecitabine—esophageal cancer	0.0092	0.0207	CcSEcCtD
Isradipine—Amlodipine—CA1—esophageal cancer	0.00797	0.228	CrCbGaD
Isradipine—Raised liver function tests—Methotrexate—esophageal cancer	0.00749	0.0169	CcSEcCtD
Isradipine—Throat sore—Capecitabine—esophageal cancer	0.00644	0.0145	CcSEcCtD
Isradipine—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.00638	0.0144	CcSEcCtD
Isradipine—Ventricular fibrillation—Capecitabine—esophageal cancer	0.00606	0.0137	CcSEcCtD
Isradipine—CACNA1H—smooth muscle tissue—esophageal cancer	0.00604	0.0923	CbGeAlD
Isradipine—Fluid retention—Cisplatin—esophageal cancer	0.00598	0.0135	CcSEcCtD
Isradipine—Tingling sensation—Capecitabine—esophageal cancer	0.00578	0.013	CcSEcCtD
Isradipine—Polyuria—Cisplatin—esophageal cancer	0.00521	0.0117	CcSEcCtD
Isradipine—Oropharyngeal pain—Capecitabine—esophageal cancer	0.00511	0.0115	CcSEcCtD
Isradipine—Nilvadipine—CYP2A6—esophageal cancer	0.00503	0.144	CrCbGaD
Isradipine—Nocturia—Capecitabine—esophageal cancer	0.00501	0.0113	CcSEcCtD
Isradipine—CACNA2D2—lung—esophageal cancer	0.00491	0.0751	CbGeAlD
Isradipine—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00467	0.0105	CcSEcCtD
Isradipine—CACNA1C—smooth muscle tissue—esophageal cancer	0.0046	0.0704	CbGeAlD
Isradipine—CACNB2—digestive system—esophageal cancer	0.00451	0.0689	CbGeAlD
Isradipine—Fluid retention—Capecitabine—esophageal cancer	0.00441	0.00994	CcSEcCtD
Isradipine—Amlodipine—CYP2A6—esophageal cancer	0.00433	0.124	CrCbGaD
Isradipine—Urine output increased—Capecitabine—esophageal cancer	0.0042	0.00947	CcSEcCtD
Isradipine—Breast disorder—Cisplatin—esophageal cancer	0.00413	0.00932	CcSEcCtD
Isradipine—Cramp muscle—Cisplatin—esophageal cancer	0.00412	0.00928	CcSEcCtD
Isradipine—Nifedipine—ABCC2—esophageal cancer	0.00392	0.112	CrCbGaD
Isradipine—Nifedipine—CYP2A6—esophageal cancer	0.00387	0.111	CrCbGaD
Isradipine—Polyuria—Capecitabine—esophageal cancer	0.00384	0.00866	CcSEcCtD
Isradipine—Abdominal discomfort—Cisplatin—esophageal cancer	0.00379	0.00854	CcSEcCtD
Isradipine—CACNB2—lung—esophageal cancer	0.00376	0.0575	CbGeAlD
Isradipine—CACNA1C—digestive system—esophageal cancer	0.00364	0.0556	CbGeAlD
Isradipine—Libido decreased—Capecitabine—esophageal cancer	0.00363	0.0082	CcSEcCtD
Isradipine—Atrial fibrillation—Capecitabine—esophageal cancer	0.00356	0.00802	CcSEcCtD
Isradipine—CACNA2D1—lung—esophageal cancer	0.00353	0.054	CbGeAlD
Isradipine—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00347	0.00783	CcSEcCtD
Isradipine—Myocardial infarction—Cisplatin—esophageal cancer	0.00345	0.00779	CcSEcCtD
Isradipine—Cardiac failure—Capecitabine—esophageal cancer	0.00345	0.00779	CcSEcCtD
Isradipine—Lethargy—Capecitabine—esophageal cancer	0.00344	0.00776	CcSEcCtD
Isradipine—Cerebrovascular accident—Capecitabine—esophageal cancer	0.00344	0.00776	CcSEcCtD
Isradipine—Pain in extremity—Capecitabine—esophageal cancer	0.00337	0.0076	CcSEcCtD
Isradipine—CACNA2D2—lymph node—esophageal cancer	0.00336	0.0513	CbGeAlD
Isradipine—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00334	0.00754	CcSEcCtD
Isradipine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00333	0.00751	CcSEcCtD
Isradipine—CACNA1D—lung—esophageal cancer	0.00329	0.0503	CbGeAlD
Isradipine—Bradycardia—Cisplatin—esophageal cancer	0.00322	0.00726	CcSEcCtD
Isradipine—Urine output increased—Methotrexate—esophageal cancer	0.00313	0.00705	CcSEcCtD
Isradipine—Urinary tract disorder—Cisplatin—esophageal cancer	0.00312	0.00704	CcSEcCtD
Isradipine—Liver function test abnormal—Capecitabine—esophageal cancer	0.00311	0.00702	CcSEcCtD
Isradipine—Connective tissue disorder—Cisplatin—esophageal cancer	0.00311	0.00701	CcSEcCtD
Isradipine—Urethral disorder—Cisplatin—esophageal cancer	0.0031	0.00699	CcSEcCtD
Isradipine—Gynaecomastia—Methotrexate—esophageal cancer	0.00309	0.00697	CcSEcCtD
Isradipine—Visual impairment—Cisplatin—esophageal cancer	0.00305	0.00687	CcSEcCtD
Isradipine—Breast disorder—Capecitabine—esophageal cancer	0.00305	0.00687	CcSEcCtD
Isradipine—CACNA1C—lung—esophageal cancer	0.00304	0.0464	CbGeAlD
Isradipine—Eye disorder—Cisplatin—esophageal cancer	0.00296	0.00667	CcSEcCtD
Isradipine—Flushing—Cisplatin—esophageal cancer	0.00294	0.00662	CcSEcCtD
Isradipine—Cardiac disorder—Cisplatin—esophageal cancer	0.00294	0.00662	CcSEcCtD
Isradipine—Polyuria—Methotrexate—esophageal cancer	0.00286	0.00644	CcSEcCtD
Isradipine—Immune system disorder—Cisplatin—esophageal cancer	0.00286	0.00644	CcSEcCtD
Isradipine—Mediastinal disorder—Cisplatin—esophageal cancer	0.00285	0.00643	CcSEcCtD
Isradipine—Angina pectoris—Capecitabine—esophageal cancer	0.00284	0.0064	CcSEcCtD
Isradipine—Abdominal discomfort—Capecitabine—esophageal cancer	0.00279	0.0063	CcSEcCtD
Isradipine—Malnutrition—Cisplatin—esophageal cancer	0.00275	0.00621	CcSEcCtD
Isradipine—CACNA1H—lymph node—esophageal cancer	0.00273	0.0416	CbGeAlD
Isradipine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00266	0.006	CcSEcCtD
Isradipine—Weight increased—Capecitabine—esophageal cancer	0.00265	0.00598	CcSEcCtD
Isradipine—Visual disturbance—Methotrexate—esophageal cancer	0.00265	0.00597	CcSEcCtD
Isradipine—Muscle spasms—Cisplatin—esophageal cancer	0.00265	0.00597	CcSEcCtD
Isradipine—Vision blurred—Cisplatin—esophageal cancer	0.0026	0.00585	CcSEcCtD
Isradipine—Depression—Capecitabine—esophageal cancer	0.00259	0.00584	CcSEcCtD
Isradipine—CACNB2—lymph node—esophageal cancer	0.00257	0.0393	CbGeAlD
Isradipine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00256	0.00577	CcSEcCtD
Isradipine—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00256	0.00577	CcSEcCtD
Isradipine—Lethargy—Methotrexate—esophageal cancer	0.00256	0.00577	CcSEcCtD
Isradipine—Ill-defined disorder—Cisplatin—esophageal cancer	0.00255	0.00576	CcSEcCtD
Isradipine—Myocardial infarction—Capecitabine—esophageal cancer	0.00255	0.00574	CcSEcCtD
Isradipine—Anaemia—Cisplatin—esophageal cancer	0.00254	0.00574	CcSEcCtD
Isradipine—Malaise—Cisplatin—esophageal cancer	0.00248	0.0056	CcSEcCtD
Isradipine—Leukopenia—Cisplatin—esophageal cancer	0.00246	0.00556	CcSEcCtD
Isradipine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00246	0.00554	CcSEcCtD
Isradipine—CACNA2D1—lymph node—esophageal cancer	0.00242	0.0369	CbGeAlD
Isradipine—Bradycardia—Capecitabine—esophageal cancer	0.00237	0.00535	CcSEcCtD
Isradipine—Anxiety—Cisplatin—esophageal cancer	0.00234	0.00527	CcSEcCtD
Isradipine—Hepatitis—Capecitabine—esophageal cancer	0.00233	0.00526	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00233	0.00525	CcSEcCtD
Isradipine—Hypoaesthesia—Capecitabine—esophageal cancer	0.00232	0.00523	CcSEcCtD
Isradipine—Liver function test abnormal—Methotrexate—esophageal cancer	0.00232	0.00522	CcSEcCtD
Isradipine—Discomfort—Cisplatin—esophageal cancer	0.00232	0.00522	CcSEcCtD
Isradipine—Urinary tract disorder—Capecitabine—esophageal cancer	0.0023	0.00519	CcSEcCtD
Isradipine—Oedema peripheral—Capecitabine—esophageal cancer	0.0023	0.00518	CcSEcCtD
Isradipine—Connective tissue disorder—Capecitabine—esophageal cancer	0.00229	0.00517	CcSEcCtD
Isradipine—Urethral disorder—Capecitabine—esophageal cancer	0.00229	0.00515	CcSEcCtD
Isradipine—Breast disorder—Methotrexate—esophageal cancer	0.00227	0.00511	CcSEcCtD
Isradipine—CACNA1D—lymph node—esophageal cancer	0.00225	0.0344	CbGeAlD
Isradipine—Oedema—Cisplatin—esophageal cancer	0.00225	0.00507	CcSEcCtD
Isradipine—Anaphylactic shock—Cisplatin—esophageal cancer	0.00225	0.00507	CcSEcCtD
Isradipine—Visual impairment—Capecitabine—esophageal cancer	0.00225	0.00507	CcSEcCtD
Isradipine—Nervous system disorder—Cisplatin—esophageal cancer	0.0022	0.00497	CcSEcCtD
Isradipine—Thrombocytopenia—Cisplatin—esophageal cancer	0.0022	0.00496	CcSEcCtD
Isradipine—Tachycardia—Cisplatin—esophageal cancer	0.00219	0.00495	CcSEcCtD
Isradipine—Skin disorder—Cisplatin—esophageal cancer	0.00218	0.00492	CcSEcCtD
Isradipine—Eye disorder—Capecitabine—esophageal cancer	0.00218	0.00491	CcSEcCtD
Isradipine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00217	0.0049	CcSEcCtD
Isradipine—Cardiac disorder—Capecitabine—esophageal cancer	0.00216	0.00488	CcSEcCtD
Isradipine—Flushing—Capecitabine—esophageal cancer	0.00216	0.00488	CcSEcCtD
Isradipine—Angiopathy—Capecitabine—esophageal cancer	0.00212	0.00477	CcSEcCtD
Isradipine—Immune system disorder—Capecitabine—esophageal cancer	0.00211	0.00475	CcSEcCtD
Isradipine—Mediastinal disorder—Capecitabine—esophageal cancer	0.0021	0.00474	CcSEcCtD
Isradipine—Hypotension—Cisplatin—esophageal cancer	0.0021	0.00474	CcSEcCtD
Isradipine—Abdominal discomfort—Methotrexate—esophageal cancer	0.00208	0.00469	CcSEcCtD
Isradipine—CACNA1C—lymph node—esophageal cancer	0.00208	0.0317	CbGeAlD
Isradipine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00205	0.00462	CcSEcCtD
Isradipine—Mental disorder—Capecitabine—esophageal cancer	0.00204	0.00461	CcSEcCtD
Isradipine—Malnutrition—Capecitabine—esophageal cancer	0.00203	0.00458	CcSEcCtD
Isradipine—Paraesthesia—Cisplatin—esophageal cancer	0.00202	0.00455	CcSEcCtD
Isradipine—Dyspnoea—Cisplatin—esophageal cancer	0.002	0.00452	CcSEcCtD
Isradipine—Nisoldipine—ABCB1—esophageal cancer	0.002	0.0573	CrCbGaD
Isradipine—Erectile dysfunction—Methotrexate—esophageal cancer	0.002	0.0045	CcSEcCtD
Isradipine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00198	0.00446	CcSEcCtD
Isradipine—Back pain—Capecitabine—esophageal cancer	0.00196	0.00443	CcSEcCtD
Isradipine—Decreased appetite—Cisplatin—esophageal cancer	0.00195	0.00441	CcSEcCtD
Isradipine—Muscle spasms—Capecitabine—esophageal cancer	0.00195	0.0044	CcSEcCtD
Isradipine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00194	0.00438	CcSEcCtD
Isradipine—Drowsiness—Methotrexate—esophageal cancer	0.00193	0.00436	CcSEcCtD
Isradipine—Depression—Methotrexate—esophageal cancer	0.00193	0.00435	CcSEcCtD
Isradipine—Vision blurred—Capecitabine—esophageal cancer	0.00191	0.00431	CcSEcCtD
Isradipine—Ill-defined disorder—Capecitabine—esophageal cancer	0.00188	0.00425	CcSEcCtD
Isradipine—Anaemia—Capecitabine—esophageal cancer	0.00188	0.00423	CcSEcCtD
Isradipine—Nitrendipine—ABCB1—esophageal cancer	0.00187	0.0536	CrCbGaD
Isradipine—Feeling abnormal—Cisplatin—esophageal cancer	0.00185	0.00418	CcSEcCtD
Isradipine—Malaise—Capecitabine—esophageal cancer	0.00183	0.00413	CcSEcCtD
Isradipine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00183	0.00412	CcSEcCtD
Isradipine—Syncope—Capecitabine—esophageal cancer	0.00182	0.0041	CcSEcCtD
Isradipine—Leukopenia—Capecitabine—esophageal cancer	0.00182	0.0041	CcSEcCtD
Isradipine—Palpitations—Capecitabine—esophageal cancer	0.00179	0.00404	CcSEcCtD
Isradipine—Loss of consciousness—Capecitabine—esophageal cancer	0.00178	0.00402	CcSEcCtD
Isradipine—Cough—Capecitabine—esophageal cancer	0.00177	0.00399	CcSEcCtD
Isradipine—Hepatitis—Methotrexate—esophageal cancer	0.00174	0.00391	CcSEcCtD
Isradipine—Arthralgia—Capecitabine—esophageal cancer	0.00173	0.0039	CcSEcCtD
Isradipine—Chest pain—Capecitabine—esophageal cancer	0.00173	0.0039	CcSEcCtD
Isradipine—Anxiety—Capecitabine—esophageal cancer	0.00172	0.00388	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00172	0.00387	CcSEcCtD
Isradipine—Urinary tract disorder—Methotrexate—esophageal cancer	0.00171	0.00387	CcSEcCtD
Isradipine—Discomfort—Capecitabine—esophageal cancer	0.00171	0.00385	CcSEcCtD
Isradipine—Urethral disorder—Methotrexate—esophageal cancer	0.0017	0.00384	CcSEcCtD
Isradipine—Dry mouth—Capecitabine—esophageal cancer	0.00169	0.00381	CcSEcCtD
Isradipine—Visual impairment—Methotrexate—esophageal cancer	0.00167	0.00377	CcSEcCtD
Isradipine—Oedema—Capecitabine—esophageal cancer	0.00166	0.00374	CcSEcCtD
Isradipine—Shock—Capecitabine—esophageal cancer	0.00163	0.00368	CcSEcCtD
Isradipine—Nervous system disorder—Capecitabine—esophageal cancer	0.00162	0.00366	CcSEcCtD
Isradipine—Eye disorder—Methotrexate—esophageal cancer	0.00162	0.00366	CcSEcCtD
Isradipine—Thrombocytopenia—Capecitabine—esophageal cancer	0.00162	0.00366	CcSEcCtD
Isradipine—Tachycardia—Capecitabine—esophageal cancer	0.00162	0.00365	CcSEcCtD
Isradipine—Asthenia—Cisplatin—esophageal cancer	0.00161	0.00364	CcSEcCtD
Isradipine—Amlodipine—ABCB1—esophageal cancer	0.00161	0.0461	CrCbGaD
Isradipine—Cardiac disorder—Methotrexate—esophageal cancer	0.00161	0.00363	CcSEcCtD
Isradipine—Skin disorder—Capecitabine—esophageal cancer	0.00161	0.00363	CcSEcCtD
Isradipine—Hyperhidrosis—Capecitabine—esophageal cancer	0.0016	0.00361	CcSEcCtD
Isradipine—Angiopathy—Methotrexate—esophageal cancer	0.00157	0.00355	CcSEcCtD
Isradipine—Immune system disorder—Methotrexate—esophageal cancer	0.00157	0.00354	CcSEcCtD
Isradipine—Mediastinal disorder—Methotrexate—esophageal cancer	0.00156	0.00353	CcSEcCtD
Isradipine—Hypotension—Capecitabine—esophageal cancer	0.00155	0.00349	CcSEcCtD
Isradipine—Diarrhoea—Cisplatin—esophageal cancer	0.00154	0.00347	CcSEcCtD
Isradipine—Mental disorder—Methotrexate—esophageal cancer	0.00152	0.00343	CcSEcCtD
Isradipine—Malnutrition—Methotrexate—esophageal cancer	0.00151	0.00341	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00151	0.0034	CcSEcCtD
Isradipine—Insomnia—Capecitabine—esophageal cancer	0.0015	0.00338	CcSEcCtD
Isradipine—Felodipine—ABCB1—esophageal cancer	0.00149	0.0426	CrCbGaD
Isradipine—Paraesthesia—Capecitabine—esophageal cancer	0.00149	0.00335	CcSEcCtD
Isradipine—Dyspnoea—Capecitabine—esophageal cancer	0.00148	0.00333	CcSEcCtD
Isradipine—Back pain—Methotrexate—esophageal cancer	0.00146	0.0033	CcSEcCtD
Isradipine—Dyspepsia—Capecitabine—esophageal cancer	0.00146	0.00329	CcSEcCtD
Isradipine—Nifedipine—ABCB1—esophageal cancer	0.00144	0.0412	CrCbGaD
Isradipine—Decreased appetite—Capecitabine—esophageal cancer	0.00144	0.00325	CcSEcCtD
Isradipine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00143	0.00323	CcSEcCtD
Isradipine—Vomiting—Cisplatin—esophageal cancer	0.00143	0.00322	CcSEcCtD
Isradipine—Fatigue—Capecitabine—esophageal cancer	0.00143	0.00322	CcSEcCtD
Isradipine—Vision blurred—Methotrexate—esophageal cancer	0.00142	0.00321	CcSEcCtD
Isradipine—Nicardipine—ABCB1—esophageal cancer	0.00142	0.0406	CrCbGaD
Isradipine—Rash—Cisplatin—esophageal cancer	0.00142	0.0032	CcSEcCtD
Isradipine—Constipation—Capecitabine—esophageal cancer	0.00142	0.00319	CcSEcCtD
Isradipine—Dermatitis—Cisplatin—esophageal cancer	0.00142	0.00319	CcSEcCtD
Isradipine—Ill-defined disorder—Methotrexate—esophageal cancer	0.0014	0.00316	CcSEcCtD
Isradipine—Anaemia—Methotrexate—esophageal cancer	0.0014	0.00315	CcSEcCtD
Isradipine—Feeling abnormal—Capecitabine—esophageal cancer	0.00137	0.00308	CcSEcCtD
Isradipine—Malaise—Methotrexate—esophageal cancer	0.00136	0.00307	CcSEcCtD
Isradipine—Leukopenia—Methotrexate—esophageal cancer	0.00135	0.00305	CcSEcCtD
Isradipine—CYP3A4—digestive system—esophageal cancer	0.00134	0.0205	CbGeAlD
Isradipine—Nausea—Cisplatin—esophageal cancer	0.00133	0.00301	CcSEcCtD
Isradipine—Cough—Methotrexate—esophageal cancer	0.00132	0.00297	CcSEcCtD
Isradipine—Urticaria—Capecitabine—esophageal cancer	0.00132	0.00297	CcSEcCtD
Isradipine—Chest pain—Methotrexate—esophageal cancer	0.00129	0.0029	CcSEcCtD
Isradipine—Arthralgia—Methotrexate—esophageal cancer	0.00129	0.0029	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00128	0.00288	CcSEcCtD
Isradipine—Discomfort—Methotrexate—esophageal cancer	0.00127	0.00287	CcSEcCtD
Isradipine—Anaphylactic shock—Methotrexate—esophageal cancer	0.00123	0.00278	CcSEcCtD
Isradipine—Nervous system disorder—Methotrexate—esophageal cancer	0.00121	0.00273	CcSEcCtD
Isradipine—Thrombocytopenia—Methotrexate—esophageal cancer	0.00121	0.00272	CcSEcCtD
Isradipine—Skin disorder—Methotrexate—esophageal cancer	0.0012	0.0027	CcSEcCtD
Isradipine—Hyperhidrosis—Methotrexate—esophageal cancer	0.00119	0.00269	CcSEcCtD
Isradipine—Asthenia—Capecitabine—esophageal cancer	0.00119	0.00268	CcSEcCtD
Isradipine—Pruritus—Capecitabine—esophageal cancer	0.00117	0.00264	CcSEcCtD
Isradipine—Hypotension—Methotrexate—esophageal cancer	0.00115	0.0026	CcSEcCtD
Isradipine—Diarrhoea—Capecitabine—esophageal cancer	0.00113	0.00256	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00112	0.00253	CcSEcCtD
Isradipine—Insomnia—Methotrexate—esophageal cancer	0.00112	0.00252	CcSEcCtD
Isradipine—Paraesthesia—Methotrexate—esophageal cancer	0.00111	0.0025	CcSEcCtD
Isradipine—Dyspnoea—Methotrexate—esophageal cancer	0.0011	0.00248	CcSEcCtD
Isradipine—Somnolence—Methotrexate—esophageal cancer	0.0011	0.00247	CcSEcCtD
Isradipine—Dizziness—Capecitabine—esophageal cancer	0.0011	0.00247	CcSEcCtD
Isradipine—Dyspepsia—Methotrexate—esophageal cancer	0.00109	0.00245	CcSEcCtD
Isradipine—Decreased appetite—Methotrexate—esophageal cancer	0.00107	0.00242	CcSEcCtD
Isradipine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00106	0.0024	CcSEcCtD
Isradipine—Fatigue—Methotrexate—esophageal cancer	0.00106	0.0024	CcSEcCtD
Isradipine—Vomiting—Capecitabine—esophageal cancer	0.00105	0.00238	CcSEcCtD
Isradipine—Rash—Capecitabine—esophageal cancer	0.00104	0.00236	CcSEcCtD
Isradipine—Dermatitis—Capecitabine—esophageal cancer	0.00104	0.00235	CcSEcCtD
Isradipine—Headache—Capecitabine—esophageal cancer	0.00104	0.00234	CcSEcCtD
Isradipine—Feeling abnormal—Methotrexate—esophageal cancer	0.00102	0.00229	CcSEcCtD
Isradipine—Nausea—Capecitabine—esophageal cancer	0.000984	0.00222	CcSEcCtD
Isradipine—Urticaria—Methotrexate—esophageal cancer	0.00098	0.00221	CcSEcCtD
Isradipine—Asthenia—Methotrexate—esophageal cancer	0.000885	0.002	CcSEcCtD
Isradipine—Pruritus—Methotrexate—esophageal cancer	0.000872	0.00197	CcSEcCtD
Isradipine—Diarrhoea—Methotrexate—esophageal cancer	0.000844	0.0019	CcSEcCtD
Isradipine—Dizziness—Methotrexate—esophageal cancer	0.000815	0.00184	CcSEcCtD
Isradipine—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.0008	0.00175	CbGpPWpGaD
Isradipine—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000792	0.00174	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—SMAD4—esophageal cancer	0.000791	0.00174	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—ABL1—esophageal cancer	0.000789	0.00173	CbGpPWpGaD
Isradipine—Vomiting—Methotrexate—esophageal cancer	0.000784	0.00177	CcSEcCtD
Isradipine—CACNA1D—Metabolism—BLVRB—esophageal cancer	0.000778	0.00171	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—SLC52A3—esophageal cancer	0.000778	0.00171	CbGpPWpGaD
Isradipine—Rash—Methotrexate—esophageal cancer	0.000778	0.00175	CcSEcCtD
Isradipine—Dermatitis—Methotrexate—esophageal cancer	0.000777	0.00175	CcSEcCtD
Isradipine—Headache—Methotrexate—esophageal cancer	0.000773	0.00174	CcSEcCtD
Isradipine—CACNA1D—Alzheimers Disease—TP53—esophageal cancer	0.00077	0.00169	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ADH1B—esophageal cancer	0.00076	0.00167	CbGpPWpGaD
Isradipine—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.000752	0.00165	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—ACTB—esophageal cancer	0.000739	0.00162	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—KDR—esophageal cancer	0.000736	0.00161	CbGpPWpGaD
Isradipine—Nausea—Methotrexate—esophageal cancer	0.000732	0.00165	CcSEcCtD
Isradipine—CACNA2D2—Metabolism—TYMP—esophageal cancer	0.000726	0.00159	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—CTNNA1—esophageal cancer	0.000726	0.00159	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—MET—esophageal cancer	0.000721	0.00158	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CYP26A1—esophageal cancer	0.000706	0.00155	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CA1—esophageal cancer	0.000699	0.00153	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—SLC10A2—esophageal cancer	0.000699	0.00153	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—ABL1—esophageal cancer	0.000693	0.00152	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—ABL1—esophageal cancer	0.000693	0.00152	CbGpPWpGaD
Isradipine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000692	0.00152	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ALOX15—esophageal cancer	0.000688	0.00151	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—BLVRB—esophageal cancer	0.000684	0.0015	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—SLC52A3—esophageal cancer	0.000684	0.0015	CbGpPWpGaD
Isradipine—CACNA1C—Alzheimers Disease—TP53—esophageal cancer	0.000676	0.00148	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—SMAD4—esophageal cancer	0.000672	0.00147	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—SLC10A2—esophageal cancer	0.000662	0.00145	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CA1—esophageal cancer	0.000662	0.00145	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GSTO1—esophageal cancer	0.000657	0.00144	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—TPI1—esophageal cancer	0.000657	0.00144	CbGpPWpGaD
Isradipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00065	0.00143	CbGpPWpGaD
Isradipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000647	0.00142	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CA2—esophageal cancer	0.000639	0.0014	CbGpPWpGaD
Isradipine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000638	0.0014	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—KDR—esophageal cancer	0.000631	0.00138	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ALDOB—esophageal cancer	0.00063	0.00138	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—ERBB2—esophageal cancer	0.000621	0.00136	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—KDR—esophageal cancer	0.000619	0.00136	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MET—esophageal cancer	0.000618	0.00135	CbGpPWpGaD
Isradipine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000617	0.00135	CbGpPWpGaD
Isradipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000608	0.00133	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GAPDH—esophageal cancer	0.000606	0.00133	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MET—esophageal cancer	0.000606	0.00133	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CA2—esophageal cancer	0.000605	0.00133	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CRABP1—esophageal cancer	0.000601	0.00132	CbGpPWpGaD
Isradipine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.0006	0.00132	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—KDR—esophageal cancer	0.000598	0.00131	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000595	0.0013	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—ABL1—esophageal cancer	0.000595	0.0013	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PLCE1—esophageal cancer	0.000594	0.0013	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ADH7—esophageal cancer	0.000594	0.0013	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MET—esophageal cancer	0.000585	0.00128	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—NOTCH1—esophageal cancer	0.000583	0.00128	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CA1—esophageal cancer	0.000581	0.00127	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—SLC10A2—esophageal cancer	0.000581	0.00127	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—SMAD4—esophageal cancer	0.000576	0.00126	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GNG7—esophageal cancer	0.000571	0.00125	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—ABL1—esophageal cancer	0.000563	0.00123	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PLCE1—esophageal cancer	0.000562	0.00123	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ADH7—esophageal cancer	0.000562	0.00123	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—SMAD4—esophageal cancer	0.000545	0.0012	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ALDH2—esophageal cancer	0.000535	0.00117	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CA2—esophageal cancer	0.000532	0.00117	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—CREBBP—esophageal cancer	0.000529	0.00116	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—ERBB2—esophageal cancer	0.000527	0.00115	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—KDR—esophageal cancer	0.000526	0.00115	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—KDR—esophageal cancer	0.000525	0.00115	CbGpPWpGaD
Isradipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000524	0.00115	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000522	0.00114	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ADH1B—esophageal cancer	0.000521	0.00114	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MET—esophageal cancer	0.000514	0.00113	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MET—esophageal cancer	0.000514	0.00113	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GSTT1—esophageal cancer	0.000509	0.00112	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CYP2A6—esophageal cancer	0.000503	0.0011	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—TYMP—esophageal cancer	0.000498	0.00109	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—NOTCH1—esophageal cancer	0.000495	0.00109	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—ABL1—esophageal cancer	0.000495	0.00108	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ADH7—esophageal cancer	0.000494	0.00108	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PLCE1—esophageal cancer	0.000494	0.00108	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ADH1B—esophageal cancer	0.000493	0.00108	CbGpPWpGaD
Isradipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000493	0.00108	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000485	0.00106	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP26A1—esophageal cancer	0.000484	0.00106	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—SMAD4—esophageal cancer	0.000479	0.00105	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000478	0.00105	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PTGS1—esophageal cancer	0.000477	0.00105	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ENO1—esophageal cancer	0.000477	0.00105	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ALOX15—esophageal cancer	0.000472	0.00103	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—TYMP—esophageal cancer	0.000471	0.00103	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PSME2—esophageal cancer	0.00047	0.00103	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PSME1—esophageal cancer	0.00047	0.00103	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP26A1—esophageal cancer	0.000459	0.00101	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—ERBB2—esophageal cancer	0.000452	0.00099	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000451	0.000988	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—KDR—esophageal cancer	0.000451	0.000988	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTO1—esophageal cancer	0.00045	0.000987	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—TPI1—esophageal cancer	0.00045	0.000987	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—CREBBP—esophageal cancer	0.000449	0.000984	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ALOX15—esophageal cancer	0.000447	0.00098	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000445	0.000975	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—ERBB2—esophageal cancer	0.000443	0.000971	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MET—esophageal cancer	0.000441	0.000967	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ADH1B—esophageal cancer	0.000433	0.00095	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ALDOB—esophageal cancer	0.000432	0.000946	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—EGFR—esophageal cancer	0.00043	0.000943	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—ERBB2—esophageal cancer	0.000428	0.000938	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—KDR—esophageal cancer	0.000427	0.000935	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—TPI1—esophageal cancer	0.000426	0.000935	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTO1—esophageal cancer	0.000426	0.000935	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—NOTCH1—esophageal cancer	0.000424	0.00093	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MET—esophageal cancer	0.000418	0.000915	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GAPDH—esophageal cancer	0.000415	0.000911	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—TYMP—esophageal cancer	0.000414	0.000908	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CRABP1—esophageal cancer	0.000412	0.000903	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ALDOB—esophageal cancer	0.000409	0.000896	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CYP1B1—esophageal cancer	0.000406	0.00089	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP26A1—esophageal cancer	0.000403	0.000883	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—NOTCH1—esophageal cancer	0.000402	0.000881	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GAPDH—esophageal cancer	0.000393	0.000862	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ALOX15—esophageal cancer	0.000393	0.000861	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GNG7—esophageal cancer	0.000392	0.000858	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CRABP1—esophageal cancer	0.00039	0.000855	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—CREBBP—esophageal cancer	0.000385	0.000844	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CYP19A1—esophageal cancer	0.000381	0.000836	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—ERBB2—esophageal cancer	0.000376	0.000824	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—ERBB2—esophageal cancer	0.000376	0.000824	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—KDR—esophageal cancer	0.000375	0.000822	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTO1—esophageal cancer	0.000375	0.000821	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—TPI1—esophageal cancer	0.000375	0.000821	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GNG7—esophageal cancer	0.000371	0.000813	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000367	0.000805	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ALDH2—esophageal cancer	0.000367	0.000804	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MET—esophageal cancer	0.000367	0.000804	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—EGFR—esophageal cancer	0.000365	0.0008	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—CREBBP—esophageal cancer	0.000364	0.000799	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—EP300—esophageal cancer	0.00036	0.00079	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ALDOB—esophageal cancer	0.000359	0.000787	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—NOTCH1—esophageal cancer	0.000353	0.000774	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.000349	0.000766	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTT1—esophageal cancer	0.000349	0.000765	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—HMOX1—esophageal cancer	0.000348	0.000763	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ALDH2—esophageal cancer	0.000348	0.000762	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GAPDH—esophageal cancer	0.000346	0.000758	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000345	0.000757	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP2A6—esophageal cancer	0.000345	0.000756	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CRABP1—esophageal cancer	0.000343	0.000751	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ABCB1—esophageal cancer	0.000334	0.000732	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTT1—esophageal cancer	0.000331	0.000725	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000327	0.000718	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PTGS1—esophageal cancer	0.000327	0.000717	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ENO1—esophageal cancer	0.000327	0.000717	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP2A6—esophageal cancer	0.000327	0.000716	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GNG7—esophageal cancer	0.000326	0.000714	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PSME2—esophageal cancer	0.000322	0.000707	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PSME1—esophageal cancer	0.000322	0.000707	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—ERBB2—esophageal cancer	0.000322	0.000706	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—CREBBP—esophageal cancer	0.00032	0.000702	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—EGFR—esophageal cancer	0.000313	0.000686	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ENO1—esophageal cancer	0.00031	0.000679	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PTGS1—esophageal cancer	0.00031	0.000679	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—EGFR—esophageal cancer	0.000307	0.000673	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—EP300—esophageal cancer	0.000306	0.00067	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ALDH2—esophageal cancer	0.000305	0.000669	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PSME2—esophageal cancer	0.000305	0.000669	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PSME1—esophageal cancer	0.000305	0.000669	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—ERBB2—esophageal cancer	0.000305	0.000669	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—EGFR—esophageal cancer	0.000296	0.00065	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTT1—esophageal cancer	0.00029	0.000637	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP2A6—esophageal cancer	0.000287	0.000629	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000278	0.00061	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP1B1—esophageal cancer	0.000278	0.00061	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000275	0.000602	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ENO1—esophageal cancer	0.000272	0.000597	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PTGS1—esophageal cancer	0.000272	0.000597	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PSME1—esophageal cancer	0.000268	0.000588	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PSME2—esophageal cancer	0.000268	0.000588	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—ERBB2—esophageal cancer	0.000268	0.000588	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP1B1—esophageal cancer	0.000263	0.000577	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—EP300—esophageal cancer	0.000262	0.000575	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000262	0.000574	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP19A1—esophageal cancer	0.000261	0.000573	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—EGFR—esophageal cancer	0.000261	0.000571	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—EGFR—esophageal cancer	0.00026	0.000571	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000258	0.000566	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—EP300—esophageal cancer	0.000248	0.000544	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP19A1—esophageal cancer	0.000248	0.000543	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—HMOX1—esophageal cancer	0.000239	0.000523	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP1B1—esophageal cancer	0.000231	0.000507	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ABCB1—esophageal cancer	0.000229	0.000502	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—HMOX1—esophageal cancer	0.000226	0.000495	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—EGFR—esophageal cancer	0.000223	0.00049	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CREBBP—esophageal cancer	0.000223	0.00049	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—EP300—esophageal cancer	0.000218	0.000478	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP19A1—esophageal cancer	0.000218	0.000477	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ABCB1—esophageal cancer	0.000217	0.000475	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—EGFR—esophageal cancer	0.000212	0.000464	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—NOS3—esophageal cancer	0.0002	0.000438	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—HMOX1—esophageal cancer	0.000199	0.000435	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ABCB1—esophageal cancer	0.000191	0.000418	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—EGFR—esophageal cancer	0.000186	0.000407	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PTGS2—esophageal cancer	0.000183	0.000401	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CREBBP—esophageal cancer	0.000153	0.000336	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—EP300—esophageal cancer	0.000152	0.000333	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CREBBP—esophageal cancer	0.000145	0.000318	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000141	0.000308	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000141	0.000308	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—NOS3—esophageal cancer	0.000137	0.0003	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—NOS3—esophageal cancer	0.00013	0.000284	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CREBBP—esophageal cancer	0.000127	0.000279	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PTGS2—esophageal cancer	0.000125	0.000275	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.00012	0.000262	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CA1—esophageal cancer	0.00012	0.000262	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PTGS2—esophageal cancer	0.000119	0.00026	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NOS3—esophageal cancer	0.000114	0.00025	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CA—esophageal cancer	0.000113	0.000247	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CA2—esophageal cancer	0.000109	0.00024	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PTGS2—esophageal cancer	0.000104	0.000229	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—EP300—esophageal cancer	0.000104	0.000229	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PLCE1—esophageal cancer	0.000102	0.000223	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ADH7—esophageal cancer	0.000102	0.000223	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—EP300—esophageal cancer	9.87e-05	0.000216	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ADH1B—esophageal cancer	8.92e-05	0.000196	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—EP300—esophageal cancer	8.67e-05	0.00019	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—TYMP—esophageal cancer	8.52e-05	0.000187	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	8.29e-05	0.000182	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALOX15—esophageal cancer	8.08e-05	0.000177	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CA—esophageal cancer	7.71e-05	0.000169	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—TPI1—esophageal cancer	7.71e-05	0.000169	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTO1—esophageal cancer	7.71e-05	0.000169	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALDOB—esophageal cancer	7.39e-05	0.000162	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CA—esophageal cancer	7.3e-05	0.00016	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GAPDH—esophageal cancer	7.11e-05	0.000156	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CRABP1—esophageal cancer	7.05e-05	0.000155	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GNG7—esophageal cancer	6.71e-05	0.000147	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CA—esophageal cancer	6.42e-05	0.000141	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALDH2—esophageal cancer	6.28e-05	0.000138	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.98e-05	0.000131	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.91e-05	0.00013	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.6e-05	0.000123	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ENO1—esophageal cancer	5.6e-05	0.000123	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PSME2—esophageal cancer	5.52e-05	0.000121	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PSME1—esophageal cancer	5.52e-05	0.000121	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.76e-05	0.000104	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.48e-05	9.82e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HMOX1—esophageal cancer	4.09e-05	8.96e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.92e-05	8.6e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.62e-05	5.75e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NOS3—esophageal cancer	2.35e-05	5.14e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.15e-05	4.7e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—EP300—esophageal cancer	1.78e-05	3.91e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.32e-05	2.89e-05	CbGpPWpGaD
